Medical Condition News

RSS

Jamieson introduces UC-II undenatured collagen to relieve osteoarthritis pain

Most people think that arthritis is an inevitable part of aging. Today, Jamieson Laboratories has introduced UC-II undenatured collagen, a formulation that will turn back the clock on joint pain by naturally promoting the restoration of cartilage and inhibiting its deterioration. This new anti-aging formula taken only once daily is proven to be twice as effective as other joint remedies.

15 Jun 2011

OCuSOFT, Ardeo partner to distribute novel dry eye therapy in the U.S. and Canada

OCuSOFT, Inc., an ophthalmic pharmaceutical research, development and supply company today announced an exclusive multiyear agreement with Ardeo Health, LLC to distribute a novel dry eye therapy under license from Novagali Pharma S.A. of Evry, France, Nova23041.

15 Jun 2011

ImpactRx expands nationwide network of high-value, iPhone-connected psychiatrists

ImpactRx, the pioneer in measuring the impact of promotion on physician prescribing behavior announced today that it has expanded its nationwide network of high-value, iPhone-connected physicians.

15 Jun 2011

Outpatient gastric bypass surgery linked to increased risk of complications, death

A new study of nearly 52,000 patients found that people who had gastric bypass surgery and were discharged from the hospital sooner than the national average of a two-day length of stay, experienced significantly higher rates of 30-day mortality and complications.

15 Jun 2011

VARI researchers discover protein linked to spread of head and neck cancer nasopharyngeal carcinoma

In a study recently published in Cancer Research, Van Andel Research Institute (VARI) researchers found a protein that could help predict the spread of the head and neck cancer nasopharyngeal carcinoma (NPC); this protein could also serve as part of a treatment strategy to stop the spread of the disease.

15 Jun 2011

Biomoda receives U.S. patent to expand the use of CyPath assay for treatment of cancer

Cancer diagnostics company Biomoda, Inc. received Notice of Allowance for a U.S. Patent issued today that expands on use of the CyPath assay to include patient response to cancer therapy during the treatment phase of the disease.

15 Jun 2011

Prolonged TV viewing associated with higher risk of cardiovascular disease, diabetes and all-cause mortality

In an analysis of data from several studies, watching television for 2-3 hours per day or more was associated with a higher risk of type 2 diabetes, fatal and nonfatal cardiovascular disease and all-cause death, according to a study in the June 15 issue of JAMA.

15 Jun 2011

Pfizer, pSivida partner to develop latanoprost implant for ocular hypertension and glaucoma

Drug delivery company pSivida Corp today announced it amended and restated its Research and Development Agreement with Pfizer Inc. to focus solely on the development of a long-term, sustained-release implant to deliver latanoprost for patients with ocular hypertension and glaucoma.

15 Jun 2011

Study: Early intervention can reduce recurrences, prevent psychosis

Schizophrenia is a chronic illness that most often comes on in late adolescence or young adulthood and can devastate patients' lives. Many physicians and researchers believe that early intervention can increase the chances for recovery, reduce recurrences and even prevent the warning signs of psychosis from progressing to the actual disease.

15 Jun 2011

FDA's new sunscreen regulations will help reduce skin cancer risk

The American Academy of Dermatology Association (Academy) today said that the U.S. Food and Drug Administration's (FDA) new sunscreen regulations will help Americans reduce their risk for skin cancer by guiding them to the most effective sunscreens and advising them on other sun-protection measures.

15 Jun 2011

Research reveals how humans of different ancestry process polyunsaturated fat

Over the past decade, much progress has been made regarding the understanding and promise of personalized medicine. Scientists are just beginning to consider the impact of gene-diet interactions in different populations in regards to disease prevention and treatment.

15 Jun 2011

Food coloring additives do not cause ADHD in children

When University of Maryland psychologist Andrea Chronis-Tuscano testified before a U.S. Food and Drug Administration (FDA) hearing last March, it changed her mind about possible risks of artificial food coloring for children, and drove her to look more closely at the products in her own pantry that she feeds her kids.

15 Jun 2011

Liver stiffness measurement could replace liver biopsy for evaluation of hepatitis C

Non-invasive tests for liver fibrosis, such as liver stiffness measurement or the FibroTest, can predict survival of patients with chronic hepatitis C, according to a new study in Gastroenterology, the official journal of the American Gastroenterological Association (AGA) Institute.

15 Jun 2011

Right diet is the best way to achieve optimal digestive health

A lot of Americans struggle with digestive difficulties with many not knowing how to fit in regular physical activity or make the best dietary choices that can actually promote digestive health.

15 Jun 2011

Sangart commences MP4OX Phase 2b study in acute traumatic injury

Sangart, Inc., a global biopharmaceutical company dedicated to developing life-saving medicines specifically designed to enhance the perfusion and oxygenation of ischemic tissues through targeted oxygen and other gas delivery, today announced the initiation of a Phase 2b study designed to evaluate the efficacy and safety of MP4OX treatment plus standard of care in severely injured trauma patients with lactic acidosis due to hemorrhagic shock.

15 Jun 2011

Flip-flops and baseball caps could pose a hidden health risk from skin cancer

Cheap, convenient and casual, baseball caps and flip-flops have a trendy charm. Those qualities make them must-wear accessories for teens, outdoor enthusiasts, gardeners or anyone trying to keep cool during the sweltering days of summer.

15 Jun 2011

Bayer's submission of IND for BAY 94-9343 triggers $2M milestone payment to ImmunoGen

ImmunoGen, Inc., a biotechnology company that develops targeted antibody-based anticancer products using its antibody expertise and Targeted Antibody Payload (TAP) technology, today announced that Bayer HealthCare Pharmaceuticals' submission of an Investigational New Drug (IND) application for the TAP compound, BAY 94-9343, triggers a $2 million milestone payment to ImmunoGen.

15 Jun 2011

Medical Condition News

Jamieson introduces UC-II undenatured collagen to relieve osteoarthritis pain

OCuSOFT, Ardeo partner to distribute novel dry eye therapy in the U.S. and Canada

ImpactRx expands nationwide network of high-value, iPhone-connected psychiatrists

Outpatient gastric bypass surgery linked to increased risk of complications, death

VARI researchers discover protein linked to spread of head and neck cancer nasopharyngeal carcinoma

Biomoda receives U.S. patent to expand the use of CyPath assay for treatment of cancer

Prolonged TV viewing associated with higher risk of cardiovascular disease, diabetes and all-cause mortality

Pfizer, pSivida partner to develop latanoprost implant for ocular hypertension and glaucoma

Study: Early intervention can reduce recurrences, prevent psychosis

FDA's new sunscreen regulations will help reduce skin cancer risk

Research reveals how humans of different ancestry process polyunsaturated fat

Food coloring additives do not cause ADHD in children

Liver stiffness measurement could replace liver biopsy for evaluation of hepatitis C

Right diet is the best way to achieve optimal digestive health

Sangart commences MP4OX Phase 2b study in acute traumatic injury

Flip-flops and baseball caps could pose a hidden health risk from skin cancer

Bayer's submission of IND for BAY 94-9343 triggers $2M milestone payment to ImmunoGen

Study links cysteine with obesity-related diseases

New ultrasound technique can measure blood pressure at many points in the body

DePuy Orthopaedics receives FDA approval for ceramic-on-metal total artificial hip system

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Bioprocess Efficiency with Cell Density Monitoring

Exploring electron microscopy for plant and microbial imaging at the John Innes Centre

Latest News